Alx Oncology Holdings (ALXO) Net Cash Flow (QoQ) (2019 - 2026)
Alx Oncology Holdings (ALXO) Net Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Alx Oncology Holdings |
166.27 Mn |
25.95 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
325.08% |
| Dec 31, 2025 |
-270.75% |
| Sep 30, 2025 |
415.55% |
| Jun 30, 2025 |
-143.06% |
| Mar 31, 2025 |
107.99% |
| Dec 31, 2024 |
157.92% |
| Sep 30, 2024 |
-61.96% |
| Jun 30, 2024 |
117.85% |
| Mar 31, 2024 |
-396.42% |
| Dec 31, 2023 |
115.29% |
| Sep 30, 2023 |
26.63% |
| Jun 30, 2023 |
-275.03% |
| Mar 31, 2023 |
6,294.83% |
| Dec 31, 2022 |
98.66% |
| Sep 30, 2022 |
81.31% |
| Jun 30, 2022 |
54.67% |
| Mar 31, 2022 |
-852.03% |
| Dec 31, 2021 |
13.43% |
| Sep 30, 2021 |
-24.75% |
| Jun 30, 2021 |
-355.80% |
